ADORE BEAUTY GROUP LIMITED (ABY)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ABY - ADORE BEAUTY GROUP LIMITED

FNArena Sector : Household & Personal Products

Year End: June

GICS Industry Group : No Sector

Index: ALL-ORDS | ALL-TECH

Adore Beauty Group is an Australian online retailer of beauty, skin care and fragrance products. It operates in Australia and New Zealand. It listed on the ASX in 2020.

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$4.80 23 Sep 2021	0.200 OPEN $4.60	4.35% HIGH $4.81	59,684 LOW $4.58

LAST PRICE

CHANGE +/-

CHANGE %

VOLUME

$4.80

23 Sep
2021

0.200

OPEN

$4.60

4.35%

HIGH

$4.81

59,684

LOW

$4.58

TARGET
$6.00 25.0% upside

OTHER COMPANIES IN THE SAME SECTOR
AHY . BRG . GFY . GUD . MYR . TRS . SSG . BWX . DSK .

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY20 Actual	FY21 Actual	FY22 Forecast	FY23 Forecast
EPS (cps)	xxx	N/A	3.8	xxx
DPS (cps)	xxx	0.0	0.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	N/A	N/A	xxx
PE Ratio	xxx	N/A	132.8	xxx
Dividend Yield	xxx	N/A	0.0%	xxx
Div Pay Ratio(%)	xxx	N/A	0.0%	xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 19/05 - 9c

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2021 FactSet UK Limited. All rights reserved

Title	2018	2019	2020	2021
EPS Basic	xxx	xxx	xxx
DPS All	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	179.3 M
Book Value Per Share	xxx	xxx	xxx
Net Operating Cash Flow	xxx	xxx	xxx	M
Net Profit Margin	xxx	xxx	xxx	%

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title	2018	2019	2020	2021
Return on Assets	xxx	xxx	xxx	%
Return on Equity	xxx	xxx	xxx	%
Return on Total Capital	xxx	xxx	xxx	%
Capex	xxx	xxx	xxx	M
Capex % of Sales	xxx	xxx	xxx	%
Free Cash Flow ex dividends	xxx	xxx	xxx	M

Return on Assets

Return on Equity

Return on Total Capital

Capex

Capex % of Sales

Free Cash Flow ex dividends

This is work in progress. Bear with us. It'll be amazing.

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Morgan Stanley	xx/xx/xxxx	1	xxxxxxxxxx	$xx.xx	xx.xx%	Broker commentary and detailed analysis is available for Full Members Only. Login above or Get a Free Trial
UBS	31/08/2021	1	Buy	$6.00	25.00%	FY21 results were ahead of guidance and demonstrated improved operating momentum. UBS found it difficult to quantify the benefit from the lockdown, although sales growth of 26% in the current year to date surprised to the upside, particularly as July-August 2020 were the two highest sales months during that year. The main negative was the outlook for EBITDA margins to be 2-4% in the medium term, as the company reinvests to support top-line growth. UBS believes the market should be increasingly confident around FY22 forecasts and retains a Buy rating, raising the target to $6.00 from $5.60. FORECAST UBS forecasts a full year FY22 dividend of 0.00 cents and EPS of 3.50 cents. UBS forecasts a full year FY23 EPS of 4.80 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Morgan Stanley

xx/xx/xxxx

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

31/08/2021

Buy

$6.00

25.00%

FY21 results were ahead of guidance and demonstrated improved operating momentum.

UBS found it difficult to quantify the benefit from the lockdown, although sales growth of 26% in the current year to date surprised to the upside, particularly as July-August 2020 were the two highest sales months during that year.

The main negative was the outlook for EBITDA margins to be 2-4% in the medium term, as the company reinvests to support top-line growth.

UBS believes the market should be increasingly confident around FY22 forecasts and retains a Buy rating, raising the target to $6.00 from $5.60.

FORECAST
UBS forecasts a full year FY22 dividend of 0.00 cents and EPS of 3.50 cents.
UBS forecasts a full year FY23 EPS of 4.80 cents.

Access Stockbroker Research History >

ABY STOCK CHART

FNArena News on ABY

1	Can These Fallen Angels Regain Their Wings? Sep 08 2021 - Weekly Reports

2	FNArena Corporate Results Monitor – 31-08-2021 Aug 31 2021 - Australia

3	Rudi’s View: August Bonanza, But What’s Next? Aug 05 2021 - Rudi's View

4	BWX On The Expansion Trail May 20 2021 - Small Caps

5	The Wrap: Office, Online, Telcos, CBD, Rents Apr 30 2021 - Weekly Reports

Latest Household & Personal Products News

1	Market Misunderstands Breville’s Strategy Aug 19 2021 - Australia

2	The Reject Shop (Still) Requires A Leap Of Faith Jun 09 2021 - Australia

3	BWX On The Expansion Trail May 20 2021 - Small Caps

4	No Such Thing As Too Much Bling Mar 25 2021 - Australia

5	Adore Beauty Attracts Customer Engagement Dec 10 2020 - Small Caps

6	Breville: Better Entry Price Ahead Nov 24 2020 - Technicals

7	BWX Targets Greater International Profile Aug 24 2020 - Small Caps

8	CORRECTION: Prospects Improve Markedly For BWX Aug 07 2020 - Small Caps

9	Retailing’s Two-Speed Economy Jul 29 2020 - Weekly Reports

10	Breville’s Growth Potential Attracts Brokers Jul 13 2020 - Australia

Dividend Yield Today On Last Actual Payout :	0.00
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

ADORE BEAUTY GROUP LIMITED (ABY)
Share Price Analysis and Chart